Home >> About

News & Events

Philadelphia, PA March 13, 2021: The Temple University School of Pharmacy has launched a fundraising campaign in honor of Magid Abou-Gharbia, PhD, FRSC to support medicinal chemistry. We invite all members of our communities to donate in tribute to Dr. Abou-Gharbia.  To contribute, click to donate to the Magid Abou-Gharbia Endowed Fund online now or contact Christopher Van Vessem, Assistant Dean for Development & Alumni Relations, at cvv110@temple.edu.

Philadelphia, PA 01/20/2021: A three-year-old Philadelphia genetic engineering company spun out of Temple University has secured its first patent for its core gene-editing technology. ExpressCells was awarded the U.S. patent for its "Fast-HDR" gene editing technology, developed to create advanced cell lines for drug discovery.

Philadelphia, PA December 20, 2019 - Basic Principles of Drug Discovery and Development, a textbook written by Dr. Benjamin E Blass and published by Academic Press, is now available in Chinese (ISBN 978-7-03-063005-6). Dr. Blass’s original manuscript was translated by Dr. Renren Bai of Hangzhou Normal University, and marketed by China Science Publishing & Media Ltd. The textbook presents the multifaceted process of identifying a new drug in the modern era, providing comprehensive explanations of enabling technologies such as high throughput screening, structure based drug design, molecular modeling, pharmaceutical profiling, and translational medicine, all areas that have become critical steps in the successful development of marketable therapeutics.

Philadelphia, PA April 5th, 2020: Ten years ago, Temple University established the Moulder Center for Drug Discovery Research as a hub for further developing the scientific discoveries of faculty members and scientists. The goals of the centers included facilitating collaboration opportunities with pharmaceutical industry partners and other academic researchers, and moving discoveries made on campus into the broader research community. Now a decade later, the center has generated a measurable return on Temple's investment, The center has spun out one company, and is in the process of launching three more. Its researchers have received 12 patents, filed for more than 30, and obtained more than $7 million in grants and research contracts.

The Moulder Center for Drug Discovery Research was highlighted in Speciality Chemicals Magazine in an article entitled "A Fully Integrated Academic Drug Discovery Center."

Abu Dhabi, United Arab Emirates - Magid Abou-Gharbia served as one of three keynote speakers at the 4th annual Middle East Molecular Biology Congress and Exhibition held under the patronage of H.E. Sheikha Lubna Bint Khalid Al Qasimi  at the Zayed University Convention Center.

Dr. Wendy B. Young, Vice President of Discovery Chemistry, Genentech presented a lecture entitled "From Bench to Clinic: Potent, Selective and Reversible BTK Inhibitors" at Temple University School of Pharmacy

Washington, DC - As part of the American Chemical Society's fall 2017 natioanl meeting, Magid Abou-Gharbia served as one of three participants in the Pharma Leaders Symposium entitled “Working together to make a difference.” 

NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that Recensa Therapeutics (http://www.recensatherapeutics.com), which is developing a topical psoriasis treatment designed to reduce oxidative stress, was named “Best in Show” by the audience and “Most Fundable” by the investor panel at MABA's 1st Pitch Life Science event held on May 25, 2017 at Rockefeller University in New York City.

May 31st, 2017: Dr Magid Abou-Gharbia chairs Pharma Outsourcing Best Practices Panel at 2017 ChemSpec Europe Meeting at the Munich Trade Fair Center, Germany. 


Temple University
Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140